AMSBIO has released a new 16-page practical guide that provides a detailed overview on how blockers can be used to reduce non-specific binding in immunoassays.
Immunoassay Blocking Reagents (Blockers) are typically applied to ELISA and Lateral Flow-based assays, specifically paired monoclonal sandwich assays, competitive assays and antigen capture (IgG/IgM) assays. They work by removing interfering proteins in patient samples that could produce false results and an incorrect diagnosis. Choosing the best assay format depends on the intended application of the...
Leader in the development and manufacture of transfusion diagnostic products awarded prestigious Queen’s Award for outstanding achievement in international trade
Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that its UK subsidiary, Alba Bioscience Limited (“Alba”), has been awarded the prestigious Queen’s Award for Enterprise in the category of outstanding achievement in international trade. Alba develops, manufactures and commercializes products for the global market. The Queen’s Awards for Enterprise are...
Renowned neurodegenerative disease pioneer joins the stem cell disease model specialists
Axol Bioscience, a biotechnology company, specialising in the use of stem cell technology to manufacture disease-relevant cell based assay systems for drug discovery and disease modelling, today announced that Steve Finkbeiner, MD, PhD has joined its Scientific Advisory Board. Dr Finkbeiner is a leading neuroscientist who will guide Axol in expanding its range of induced pluripotent stem cell...
Markes International (Llantrisant, UK) has announced the launch of a new family of thermal desorption instruments for GC–MS at the Analytica 2016 trade show in Munich, Germany.
The new products, which form the ‘xr’ series, incorporate new powerful advances that offer major benefits to analytical laboratories running analyses of volatile and semi-volatile organic compounds (VOCs and SVOCs) in air and materials.
Read MoreChromatrap Customer Focused Website Goes LiveMay 23, 2016
Following extensive customer research, Chromatrap® has re-designed its website to better serve the needs of end users.
With an expanding product range, new families of ChIP validated antibodies and a suite of useful new support information including articles, application notes, video tutorials and guides a new site was required. The bright, fresh new website layout makes it easier and quicker to find the ideal Chromatrap ChIP kit for your immunoassay. “We wanted a fresh approach” said Chromatrap Marketing Director...
Genomics plc have announced that it has entered into a research collaboration with DNAnexus, the global leader in cloud-based genome informatics and data management.
The companies will work together to improve researchers’ ability to analyse population-scale sequencing data. With DNA sequencing costs continuing to fall, sequencing projects involving tens or hundreds of thousands of people are becoming increasingly common. Such projects include Genomics England’s 100,000 Genomes Project, and the Regeneron Genetics Center and Geisinger Health DiscovEHR...
Experimental “Internet of Things” System Uses Connected Devices to Enable Remote Measurement of Health and Quality of Life in Real-Time - Multi-Year Project Could Potentially Change How Clinical Trials are Conducted
Pfizer Inc. (NYSE:PFE) and IBM (NYSE:IBM) today announced a first-of-its-kind research collaboration to develop innovative remote monitoring solutions aimed at transforming how clinicians deliver care to patients suffering from Parkinson’s disease. The experimental approach will rely on a system of sensors, mobile devices, and machine learning to provide real-time, around-the-clock disease symptom information to clinicians and researchers....
Read MoreZEISS Atlas 5 May 23, 2016
ZEISS introduces an integrated solution to acquire and analyze multi-scale and multi-modal images in light, electron and X-ray microscopy
ZEISS Atlas 5 is a powerful hardware and software package that extends the capacity of ZEISS scanning electron microscopes (SEM) and focused ion beam SEMs (FIB-SEM). ZEISS Atlas 5 streamlines automatic image acquisition and lets users benefit from its efficient navigation and correlation of images from any source including light and X-ray microscopes.
New system allows label free, long time-course, live cell imaging
Phase Focus Ltd, the company pioneering a novel method for high fidelity label-free quantitative imaging, has announced the commercial launch of Livecyte, a new complete live cell imaging system for kinetic cytometry. Livecyte will enable cell biology researchers to achieve a deeper understanding of the phenotypic and kinetic behaviours of both individual and populations of cells in a label free environment...
The European Region is the first in the world to have achieved interruption of indigenous malaria transmission.
The number of indigenous malaria cases dropped from 90 712 in 1995 to zero cases in 2015. Ahead of World Malaria Day 2016, WHO announces that the European Region hit its 2015 target to wipe out malaria, thus contributing to the global goal to “End malaria for good”. Key partners funded malaria elimination efforts in European countries substantially. “This is a major milestone in Europe’s public health...
BMG LABTECH’s Readers are Used to Measure Binding Kinetics Over Minutes
Single reading events of a signaling molecule at a given time should no longer be considered as the only insightful indicator to predict the usefulness of a new drug candidate. In fact, the authors of a new study claim that it is necessary to explore the kinetic context of the binding event instead....
Findings from Sheffield Teaching Hospitals NHS Trust
Beckman Coulter today announced that the Sheffield Teaching Hospitals Virology Department is the first site to introduce the company’s DxN VERIS HBV assay* routinely. Operating on the DxN VERIS Molecular Diagnostics System, that consolidates DNA extraction, amplification and detection within a single automated instrument, the HBV assay will allow the laboratory to offer service users greater precision at...
eMolecules Inc. and World Fusion US, Inc. today announced a global partnership resulting in the integration of eMolecules’ drug discovery ecommerce solutions with World Fusion’s “Life Science Knowledge Bank” (LSKB).
“We are really excited about the opportunities that this partnership creates and we view this as a great start in our vision of enabling the Japanese marketplace to reduce the time and cost of drug discovery” said Dr. Niko Gubernator, CEO at eMolecules, Inc. “Not only does this partnership extend our reach into the Japanese marketplace, but the integration of World Fusion’s LSKB informatics platform with...
Agena Bioscience to provide Horizon’s human genomic reference standards to assess quality and performance of oncology-based assays on the MassARRAY System
Agena Bioscience (“Agena”) and Horizon Discovery Group plc (LSE: HZD) ("Horizon") today announced a Supply and Distribution agreement to launch iPLEX® reference standards for performance verification of oncology assays used on the MassARRAY® System. Under the partnership, Agena Bioscience will offer multiplexed sets of iPLEX-branded reference standards containing somatic variants in...
Cytocell Chromoprobe Multiprobe® non-human FISH probes set to benefit animal husbandry and research
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding’ award reserved for the top 10% of KTP projects...
Introducing ZEISS MultiSEM 506 acquiring more than 2 Tera pixel per hour
ZEISS has announced a new variant of the world’s fastest scanning electron microscope: ZEISS MultiSEM 506 features 91 beams working in parallel and increases the throughput of the ZEISS MultiSEM 505 by a factor of three. The unrivaled net acquisition speed of more than 2 Tera pixel per hour enables large-scaled experiments such as imaging of cubic millimeters of brain tissue at nanometer resolution for the analysis of neural circuits.
Read MoreBD Receives CE Mark for Next Generation Blood Separation TechnologyMay 19, 2016
BD Vacutainer® Barricor™ Tube Designed to Enhance Sample Quality, Improve Laboratory Efficiency and Speed Laboratory Turnaround Time
BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it obtained the CE mark in the UK and Europe for a next-generation blood separation technology that is designed to enhance sample quality, improve laboratory efficiency and reduce laboratory turnaround time. BD Vacutainer® Barricor™ tube is a single-use, plastic evacuated tube used to collect...
GÉANT, Europe?s leading collaboration on network and related infrastructure for research and education, has signed a partnership agreement with Microsoft to act as network connectivity provider for Microsoft?s Azure ExpressRoutes service.
This will connect Microsoft?s cloud services directly to Europe?s vital research and education community, and represents further growth in the portfolio of above-the-net services offered by GÉANT and its National Research and Education Network (NREN) partners to over 50 million users at 10,000 institutions. Microsoft Azure ExpressRoutes enables institutions to extend their on-premises network into the...
St Neots-based Kinesis is celebrating after being named a winner of the UK’s highest accolade for business success - The Queen’s Award for Enterprise in International Trade.
The awards are made annually by HM The Queen, and this year coincide with Her Majesty’s 90th birthday on April 21st. Kinesis are one of the select businesses recognised as winners of the 2016 Queen’s Award, which the company has received due to their outstanding success in International Trade. The award was made in recognition of achieving continuous growth in export sales over the last six years of...
PAREXEL enhances its Regulatory Cloud; leverages EMC® Documentum® for Life Sciences software solution suite to offer an end-to-end regulatory solution
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organisation, and EMC Corporation (NYSE: EMC) today announced they have entered into an alliance to offer an end-to-end Regulatory Information Management (RIM) and Regulatory Content Management solution. By combining PAREXEL® LIQUENT InSight® Regulatory Information Management platform...
The VC DNA Ladder range is a good example of the extensive choice customers have when selecting a Vivantis product
Vivantis Technologies take pride in being the one stop solution to the scientific community in molecular biology research, providing an extensive selection of products to ensure customer needs are met. The VC DNA Ladder range is a good example of the extensive choice customers have when selecting a Vivantis product. A DNA ladder of course is a marker which consists of DNA fragments of specific base pair lengths....
With the events now just a month away, we wanted to remind you that there is still time to book your place for Oxford Global’s highly anticipated 2nd Annual Formulation & Drug Delivery Congress, co-located with our inaugural Inhalation & Respiratory Drug Delivery Congress taking place on the 18-19 May 2016 in London.
Are you interested in novel large molecule formulation strategies and the latest developments in small molecule drug delivery? Would you like to expand your knowledge about inhaled drug delivery? Do not miss out on the opportunity to discuss the latest advances pertaining the formulation and drug delivery industry and network with over 150 senior level experts in this research area...
Immunoassay Blocking Reagents (Blockers) are typically applied to ELISA and Lateral Flow-based assays, specifically paired monoclonal sandwich assays, competitive assays and antigen capture (IgG/IgM) assays. They work by removing interfering proteins in patient samples that could produce false results and an incorrect diagnosis. Choosing the best assay format depends on the intended application of the...
Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that its UK subsidiary, Alba Bioscience Limited (“Alba”), has been awarded the prestigious Queen’s Award for Enterprise in the category of outstanding achievement in international trade. Alba develops, manufactures and commercializes products for the global market. The Queen’s Awards for Enterprise are...
Axol Bioscience, a biotechnology company, specialising in the use of stem cell technology to manufacture disease-relevant cell based assay systems for drug discovery and disease modelling, today announced that Steve Finkbeiner, MD, PhD has joined its Scientific Advisory Board. Dr Finkbeiner is a leading neuroscientist who will guide Axol in expanding its range of induced pluripotent stem cell...
The new products, which form the ‘xr’ series, incorporate new powerful advances that offer major benefits to analytical laboratories running analyses of volatile and semi-volatile organic compounds (VOCs and SVOCs) in air and materials.
With an expanding product range, new families of ChIP validated antibodies and a suite of useful new support information including articles, application notes, video tutorials and guides a new site was required. The bright, fresh new website layout makes it easier and quicker to find the ideal Chromatrap ChIP kit for your immunoassay. “We wanted a fresh approach” said Chromatrap Marketing Director...
The companies will work together to improve researchers’ ability to analyse population-scale sequencing data. With DNA sequencing costs continuing to fall, sequencing projects involving tens or hundreds of thousands of people are becoming increasingly common. Such projects include Genomics England’s 100,000 Genomes Project, and the Regeneron Genetics Center and Geisinger Health DiscovEHR...
Pfizer Inc. (NYSE:PFE) and IBM (NYSE:IBM) today announced a first-of-its-kind research collaboration to develop innovative remote monitoring solutions aimed at transforming how clinicians deliver care to patients suffering from Parkinson’s disease. The experimental approach will rely on a system of sensors, mobile devices, and machine learning to provide real-time, around-the-clock disease symptom information to clinicians and researchers....
Phase Focus Ltd, the company pioneering a novel method for high fidelity label-free quantitative imaging, has announced the commercial launch of Livecyte, a new complete live cell imaging system for kinetic cytometry. Livecyte will enable cell biology researchers to achieve a deeper understanding of the phenotypic and kinetic behaviours of both individual and populations of cells in a label free environment...
The number of indigenous malaria cases dropped from 90 712 in 1995 to zero cases in 2015. Ahead of World Malaria Day 2016, WHO announces that the European Region hit its 2015 target to wipe out malaria, thus contributing to the global goal to “End malaria for good”. Key partners funded malaria elimination efforts in European countries substantially. “This is a major milestone in Europe’s public health...
Single reading events of a signaling molecule at a given time should no longer be considered as the only insightful indicator to predict the usefulness of a new drug candidate. In fact, the authors of a new study claim that it is necessary to explore the kinetic context of the binding event instead....
Beckman Coulter today announced that the Sheffield Teaching Hospitals Virology Department is the first site to introduce the company’s DxN VERIS HBV assay* routinely. Operating on the DxN VERIS Molecular Diagnostics System, that consolidates DNA extraction, amplification and detection within a single automated instrument, the HBV assay will allow the laboratory to offer service users greater precision at...
“We are really excited about the opportunities that this partnership creates and we view this as a great start in our vision of enabling the Japanese marketplace to reduce the time and cost of drug discovery” said Dr. Niko Gubernator, CEO at eMolecules, Inc. “Not only does this partnership extend our reach into the Japanese marketplace, but the integration of World Fusion’s LSKB informatics platform with...
Agena Bioscience (“Agena”) and Horizon Discovery Group plc (LSE: HZD) ("Horizon") today announced a Supply and Distribution agreement to launch iPLEX® reference standards for performance verification of oncology assays used on the MassARRAY® System. Under the partnership, Agena Bioscience will offer multiplexed sets of iPLEX-branded reference standards containing somatic variants in...
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding’ award reserved for the top 10% of KTP projects...
ZEISS has announced a new variant of the world’s fastest scanning electron microscope: ZEISS MultiSEM 506 features 91 beams working in parallel and increases the throughput of the ZEISS MultiSEM 505 by a factor of three. The unrivaled net acquisition speed of more than 2 Tera pixel per hour enables large-scaled experiments such as imaging of cubic millimeters of brain tissue at nanometer resolution for the analysis of neural circuits.
BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it obtained the CE mark in the UK and Europe for a next-generation blood separation technology that is designed to enhance sample quality, improve laboratory efficiency and reduce laboratory turnaround time. BD Vacutainer® Barricor™ tube is a single-use, plastic evacuated tube used to collect...
This will connect Microsoft?s cloud services directly to Europe?s vital research and education community, and represents further growth in the portfolio of above-the-net services offered by GÉANT and its National Research and Education Network (NREN) partners to over 50 million users at 10,000 institutions. Microsoft Azure ExpressRoutes enables institutions to extend their on-premises network into the...
The awards are made annually by HM The Queen, and this year coincide with Her Majesty’s 90th birthday on April 21st. Kinesis are one of the select businesses recognised as winners of the 2016 Queen’s Award, which the company has received due to their outstanding success in International Trade. The award was made in recognition of achieving continuous growth in export sales over the last six years of...
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organisation, and EMC Corporation (NYSE: EMC) today announced they have entered into an alliance to offer an end-to-end Regulatory Information Management (RIM) and Regulatory Content Management solution. By combining PAREXEL® LIQUENT InSight® Regulatory Information Management platform...
Vivantis Technologies take pride in being the one stop solution to the scientific community in molecular biology research, providing an extensive selection of products to ensure customer needs are met. The VC DNA Ladder range is a good example of the extensive choice customers have when selecting a Vivantis product. A DNA ladder of course is a marker which consists of DNA fragments of specific base pair lengths....
Are you interested in novel large molecule formulation strategies and the latest developments in small molecule drug delivery? Would you like to expand your knowledge about inhaled drug delivery? Do not miss out on the opportunity to discuss the latest advances pertaining the formulation and drug delivery industry and network with over 150 senior level experts in this research area...